FATE THERAPEUTICS INC (FATE) Operating cash flow 2016–2025
FATE THERAPEUTICS INC (FATE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$106.1MFY2025 · since FY2016: -$29.8M → -$106.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$106.1M | +13.7% |
| FY2024 | -$122.9M | +7.1% |
| FY2023 | -$132.3M | +46.7% |
| FY2022 | -$248.2M | -52.4% |
| FY2021 | -$162.9M | -315.2% |
| FY2020 | -$39.2M | +52.8% |
| FY2019 | -$83.2M | -115.2% |
| FY2018 | -$38.6M | -5.0% |
| FY2017 | -$36.8M | -23.5% |
| FY2016 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating marginFATE Free cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →